Whitehawk Therapeutics (WHWK) Accumulated Depreciation & Amortization (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Accumulated Depreciation & Amortization of $375000.0 for Q1 2026, up 6.53% year-over-year from $352000.0 in Q1 2025, and little changed quarter-over-quarter from $374000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Accumulated Depreciation & Amortization (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 11 years of Accumulated Depreciation & Amortization data on file, last reported at $375000.0 in Q1 2026.
- Accumulated Depreciation & Amortization for Q1 2026 came in at $375000.0, up 6.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $375000.0 (up 6.53% YoY), and the FY2025 annual result was $374000.0, up 93.78% from the prior year.
- Accumulated Depreciation & Amortization held at $375000.0 in Q1 2026 per WHWK's latest filing, from $374000.0 in the prior quarter.
- Over five years, Accumulated Depreciation & Amortization peaked at $416000.0 in Q3 2024 and troughed at $38000.0 in Q1 2023.
- A 5-year average of $219411.8 and a median of $169000.0 in 2023 frame the typical range for Accumulated Depreciation & Amortization.
- The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation & Amortization tumbled 48.65% in 2023, then surged 604.0% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $159000.0 in 2022, then advanced by 6.29% to $169000.0 in 2023, then advanced by 14.2% to $193000.0 in 2024, then jumped by 93.78% to $374000.0 in 2025, then gained by 0.27% to $375000.0 in 2026.
- Business Quant data shows WHWK's Accumulated Depreciation & Amortization at $375000.0 in Q1 2026, $374000.0 in Q4 2025, and $373000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Whitehawk Therapeutics | 288.03 Mn | 164.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 375,000.00 |
| Mar 31, 2026 | 375,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Jun 30, 2025 | 368,000.00 |
| Jun 30, 2025 | 368,000.00 |
| Mar 31, 2025 | 352,000.00 |
| Mar 31, 2025 | 352,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 369,000.00 |
| Jun 30, 2024 | 369,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Dec 31, 2023 | 169,000.00 |